Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioAge Labs (BIOA) EPS (Weighted Average and Diluted) (2024 - 2025)

BioAge Labs (BIOA) has disclosed EPS (Weighted Average and Diluted) for 2 consecutive years, with -$0.72 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) fell 104.76% to -$0.72 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.24 through Dec 2025, up 69.19% year-over-year, with the annual reading at -$2.24 for FY2025, 66.21% up from the prior year.
  • EPS (Weighted Average and Diluted) hit -$0.72 in Q4 2025 for BioAge Labs, down from -$0.56 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $15.13 in Q4 2024 to a low of -$7.94 in Q2 2024.